5 of 6 Patients Achieve Objective Response, including 4 Patients with Complete Response, with Single Dose of FT596 at 900 Million Cells in Combination with Rituximab 13 of 19 Patients Achieve ...
Health care stocks were recovering modestly from their intraday lows this afternoon, with the NYSE Health Care Index falling 0.9% while the SPDR Health Care Select Sector ETF was down 0.8%. The Nasdaq ...
With a special interest in neurological disorders, Hopstem Biotechnology Co. Ltd. closed a series A++ round to raise nearly ¥100 million (US$15.5 million) to advance hNPC-01, an off-the-shelf induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results